Max India Ltd AI Stock Analysis
Want to see IN:MAXIND full AI Analyst Report?
Max India Ltd (MAXIND) AI Stock Analysis
Max India Ltd
(NSE:MAXIND)
Max India scores poorly, driven primarily by severely distressed fundamentals: five straight years of losses, collapsing gross margins, a FY2025 net loss nearly equal to total revenue, and over ₹1 billion of annual negative operating cash flow that raises funding and going-concern questions. A moderately leveraged balance sheet and projected FY2026 revenue growth of ~20.5% provide only limited offset against rapidly eroding equity. Technically, the stock trades below its 50-, 100-, and 200-day moving averages with a negative MACD, and valuation offers no support given negative earnings and no dividend. Investors should monitor liquidity, funding plans, and any credible path to profitability before considering exposure.
Max India Ltd (MAXIND) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 8.35B
- Dividend Yield
- ―
- Average Volume (3M)
- 4,477
- Price to Earnings (P/E)
- -6.4
- Beta (1Y)
- 0.87
- Revenue Growth
- 61.46%
- EPS Growth
- 28.38%
- Country
- India
- Employees
- 19
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Care Facilities
Max India Ltd Business Overview & Revenue Model
Company Description
Max India Limited focuses on delivering a range of services tailored for senior living communities. The company is actively involved in the complete lifecycle of these residential developments, from their initial creation and construction to their ow...
How the Company Makes Money
Max India Ltd primarily makes money as a holding/investment company through income and value creation from its underlying investments in senior care businesses (notably Antara Senior Living). Its earnings may therefore be driven by a combination of (...
Max India Ltd Financial Statement Overview
Summary
Financials are very weak across the board. The income statement (score 12) shows five consecutive years of net losses, a ~7.8% revenue decline in FY2025 to ₹1.45 billion, a net loss of ₹1.40 billion (net margin near -96.5%), and gross margins collapsing from ~60% to negative territory. Cash flow (score 10) is the biggest red flag, with operating cash flow at -₹1.12 billion and free cash flow at -₹1.47 billion in FY2025, and continued cash burn projected in FY2026. The balance sheet (score 38) provides only partial offset: leverage remains moderate at ~0.29 debt-to-equity, but equity has eroded from ₹6.53 billion in FY2021 to ₹3.59 billion in FY2025, total assets have shrunk, debt has more than doubled, and ROE stands at -39.1%. FY2026 estimates point to ~20.5% revenue growth and slightly reduced cash burn, but the company remains deeply unprofitable.
Income Statement
12Very NegativeBalance Sheet
38NegativeCash Flow
10Very Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.55B | 1.91B | 1.45B | 1.58B | 2.13B | 2.35B |
| Gross Profit | 330.70M | -130.70M | -26.20M | 942.71M | 1.21B | 1.06B |
| EBITDA | -560.00M | -820.80M | -1.12B | -376.40M | -45.24M | 823.00K |
| Net Income | -1.21B | -1.22B | -1.40B | -563.76M | -104.00M | -161.36M |
Balance Sheet | ||||||
| Total Assets | 6.86B | 6.69B | 6.33B | 6.84B | 7.53B | 8.54B |
| Cash, Cash Equivalents and Short-Term Investments | 1.21B | 943.80M | 1.43B | 2.96B | 3.86B | 3.99B |
| Total Debt | 1.17B | 962.10M | 1.02B | 435.65M | 453.00M | 607.63M |
| Total Liabilities | 2.91B | 2.61B | 2.74B | 1.92B | 2.11B | 2.17B |
| Stockholders Equity | 3.95B | 4.08B | 3.59B | 4.92B | 5.42B | 6.37B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -1.36B | -1.47B | -1.31B | 657.50M | 597.96M |
| Operating Cash Flow | 0 | -846.60M | -1.12B | -1.02B | 694.10M | 664.96M |
| Investing Cash Flow | 0 | -618.70M | 306.30M | 1.59B | 1.24B | 322.51M |
| Financing Cash Flow | 0 | 1.50B | -124.13M | -289.96M | -1.19B | -939.41M |
Max India Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MAXIND, the sentiment is Negative. The current price of 145.65 is below the 20-day moving average (MA) of 149.47, below the 50-day MA of 151.32, and below the 200-day MA of 156.48, indicating a bearish trend. The MACD of -1.17 indicates Negative momentum. The RSI at 43.46 is Neutral, neither overbought nor oversold. The STOCH value of 35.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MAXIND.
Max India Ltd Peers Comparison
Overall Rating
IN:NH67Neutral
IN:FORTIS64Neutral
IN:MAXHEALTH63Neutral
IN:APOLLOHOSP62Neutral
IN:ASTERDM55Neutral
IN:MAXIND29Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 67Neutral | INR 387.07B | 44.89 | ― | 0.24% | 71.40% | 1.76% | |
| 64Neutral | INR 605.02B | 58.37 | ― | 0.12% | 17.50% | 2.40% | |
| 63Neutral | INR 983.06B | 71.22 | ― | 0.20% | 15.17% | 1.63% | |
| 62Neutral | INR 1.26T | 56.24 | ― | 0.23% | 19.24% | 34.11% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | INR 654.63B | 103.73 | ― | 0.53% | 50.47% | 10.73% | |
| 29Underperform | INR 8.18B | -6.38 | ― | ― | 61.46% | 28.38% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:MAXIND | Max India Ltd | 145.65 | -54.20 | -27.12% | |
| IN:APOLLOHOSP | Apollo Hospitals Enterprise Limited | 8701.35 | 1261.96 | 16.96% | |
| IN:ASTERDM | Aster DM Healthcare Ltd. | 738.80 | 75.80 | 11.43% | |
| IN:FORTIS | Fortis Healthcare Ltd. | 805.65 | -116.32 | -12.62% | |
| IN:MAXHEALTH | Max Healthcare Institute Ltd | 1029.95 | -132.03 | -11.36% | |
| IN:NH | Narayana Hrudayalaya Ltd. | 1906.45 | -81.33 | -4.09% |
Max India Ltd Corporate Events
Max India Extends Rs 25 Crore Corporate Guarantee to Assisted Care Subsidiary
Max India Ltd has executed a corporate guarantee of Rs 25 crore in favour of Axis Bank for a credit facility being availed by its wholly owned subsidiary Antara Assisted Care Services Ltd, following board approval in May for guarantees up to Rs 75 cr...
Max India moves AGM online and urges shareholders to update KYC details
Max India Limited has scheduled its seventh Annual General Meeting for August 19, 2026, to be held via video conferencing and other audio-visual means, underscoring its continued use of virtual formats for shareholder engagement. The company is provi...
Max India announces resignation of independent director Rohit Kapoor
Max India Ltd, a listed entity on BSE and NSE under the symbol MAXIND, operates from its corporate headquarters in Gurgaon with a registered office in New Delhi and forms part of a diversified Indian business group. The company maintains a public mar...
Max India discloses resignation of independent director Rohit Kapoor
Max India Limited has announced that Non-Executive Independent Director Rohit Kapoor has resigned from the company’s board with effect from July 1, 2026. The resignation was formally notified to both the BSE and NSE in compliance with Regulation 30 o...
Max India files investor presentation with BSE and NSE
Max India Limited has released an investor presentation and notified both the BSE and NSE in compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The presentation, also available on the company’...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 19, 2026
